Connect
BCG Shortage since 2019 may be resolved soon
ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced the U.S. Food and Drug Administration (FDA) has authorized an expanded access program (EAP) that will bring a vital alternative source of BCG, a standard-of-care medicine in bladder cancer, to patients in the U.S.
https://immunitybio.com/fda-authorizes-immunitybio-to-provide-recombinant-bcg-rbcg-to-urologists-to-address-tice-bcg-shortage/
Like
Helpful
HugInterested in more discussions like this? Go to the Bladder Cancer Support Group.
Connect
That is what happened to me. My urologist said the BCG takes time to get the medicine. I had to wait about 6 weeks after they ordered the BCG drugs to start my treatments.
-
Like -
Helpful -
Hug
1 Reaction@stans2000 this is good news!! My husband was lucky in receiving BCG in 2020 but we were warned about the shortage. Delaying treatment can be a big risk with cancer. Thanks for sharing this.
-
Like -
Helpful -
Hug
1 ReactionMerck just opened their new facility in NC on March 11, 2025. When the new facility is fully operational, we expect to triple our current manufacturing capacity of TICE BCG. We anticipate that this will meet the needs of physicians and their patients for the foreseeable future. The investment in this new manufacturing facility reaffirms Merck’s longstanding commitment to producing this medicine for patients.
-
Like -
Helpful -
Hug
2 ReactionsThis is very good news. Side effects don’t seem to be too bad.
Thank God. I think this will be my husbands next therapy if it becomes available.
Fingers crossed for everyone.
It wasnt available for my husband at all. He had a different treatment. Hopefully he will be considered for this.